Advanced filters
News
The Phase 3 SAPPHIRE study aims to assess the safety and effectiveness of apitegromab used in…
News
As part of Spinal Muscular Atrophy Awareness Month, we split up our past SMA Muscles Matter videos…
News
Within Avalglucosidase alfa’s approval process, MDUK took part in a NICE Scoping Workshop in…
News
We’re delighted to announce that a new treatment for Pompe disease has been recommended for use by…
News
We were joined by Neuromuscular Care Advisors Pam Appleton, from St Georges University Hospital,…
News
Following the completion of the Phase 2 clinical trial, Fulcrum therapeutics recruited its first…
News
What is Duchenne muscular dystrophy?
Duchenne muscular dystrophy is a serious genetic condition…
News
MDUK Chair, Prof Mike Hanna and MDUK’s Director of Research, Dr Kate Adcock spoke at the event.…
News
We are delighted to announce that Muscular Dystrophy UK (MDUK) is partnering with the charity…
News
We were joined by Occupational Therapists Colin Jones and Bea Moon, parent Gerry McMenemy and…